For the first time, the Russian influenza vaccine, whose final stages of production are carried out at the MECHNIKOV Latin American Biotechnology Institute in Nicaragua, is used by the Ministry of Health of this country as part of the vaccination of people. The flu prevention campaign is taking place in Nicaragua from August 5 to
Tagged under: , ,
In 2016, SPbSRIVS produced 20 million doses of influenza vaccine, which is 12 million doses more than last year. Over the past three years, the combined output growth has been more than threefold. “In 2016, SPbSRIVS produced almost half of the total number of influenza vaccines required for the National Immunization Calendar. This makes us
250 thousand Nicaraguans will be vaccinated by the Russian vaccine for prevention of influenza produced SPbSRIVS FMBA of Russia. Campaign for vaccination of the elderly was launched in Managua on may 3, 2016. Recall that on 26 April 2016 we have started deliveries of the Russian vaccine for prevention of influenza in Cuba and in Nicaragua.
26 April 2016 the first batch of Russian vaccine for prevention of influenza was brought to Cuba and Nicaragua. All St. Petersburg Institute of Vaccines and Serums FMBA Russia will supply to Latin America about one million doses of inactivated split vaccine for the prevention of influenza. “This event cannot be overstated. The beginning of
Tagged under: ,
The new Hib vaccine has been developed from scratch by SPbSRIVS of the Russian Federal Biomedical Agency. Its development, which started less than a year ago, made use of the latest global process aspects of synthesizing similar preparations, among them the processes of cultivation, culture inactivation, purification, and modern methods of control. “Over a short